Pyruvate kinase activators for use in therapy

Pyruvate kinase activators for use in therapy

  • CN 103,608,016 A
  • Filed: 05/03/2012
  • Published: 02/26/2014
  • Est. Priority Date: 05/03/2011
  • Status: Active Application
First Claim
Patent Images

1. for extending a method that it is had to erythrocyte (RBC) life-span needing, the method comprises that (1) that makes blood contact an effective dose has compound or its pharmaceutically acceptable salt of Formula I;

  • (2) comprise and have the compound or its salt of Formula I and the compositions of carrier or (3) pharmaceutically acceptable compositions, said composition comprises compound or its pharmaceutically acceptable salt and the pharmaceutically acceptable carrier with Formula I;

    Chemical formula (I);

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×